You just read:

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

News provided by

Medical Marijuana, Inc.

21 Mar, 2017, 09:15 ET